Medicaid — the state-federal health insurance program for low-income and disabled Americans — has cut more than 22 million recipients since spring 2023.
Cara Therapeutics cuts 50% of staff and drops kidney disease program – Pharmaceutical Technology
Share this article Injectable Korsuva is approved to treat moderate to severe pruritus in CKD patients undergoing hemodialysis. Credit: Kmpzzz/Shutterstock.com Cara Therapeutics has announced plans